Platelet indices in Philadelphia-negative chronic myeloproliferative neoplasms / Indicii plachetari de volum în neoplasmele mieloproliferative cronice Philadelphia-negative

Abstract

Introduction: Philadelphia-negative chronic myeloproliferative neoplasms (Ph-MPN): polycythemia vera (PV), essential thrombocythaemia (ET), and primary myelofibrosis (PMF

Platelet indices and platelet-to-lymphocyte ratio predict coronary chronic total occlusion in patients with acute ST-elevation myocardial infarction

“…Comparability of the measured parameters was estimated by reviewing the laboratory's internal quality control measurements. MPV, PDW and P-LCR were calculated as previously described [11], with normal ranges between 7.4-11.8 fL, 10.0-22.0 fL and 13-43% respectively. Platelet-to-lymphocyte ratio was calculated by dividing the platelet count to the lymphocyte count.…”

Evaluation of thrombin generation in classical Philadelphianegative myeloproliferative neoplasms / Evaluarea generării trombinei în neoplasmele mieloproliferative Philadelphia- negative

“…In our previous study it has been demonstated that treatment with anagrelide increases mean platelet volume (MPV) and this could influence the generation of thrombin [18]. There are studies that claim the superiority of cytoreductive treatment with HU combined with aspirin in comparison with anagrelide combined with aspirin in reduction of thrombotic events and lowering leukocytes, in ET [19,20].…”